126 related articles for article (PubMed ID: 37690841)
1. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract][Full Text] [Related]
2. Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
Zhu Q; Xu D
BMC Cancer; 2021 Apr; 21(1):344. PubMed ID: 33794811
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound features value in the diagnosis and prognosis of medullary thyroid carcinoma.
Zhao J; Yang F; Wei X; Mao Y; Mu J; Zhao L; Wu J; Xin X; Zhang S; Tan J
Endocrine; 2021 Jun; 72(3):727-734. PubMed ID: 33011881
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
[TBL] [Abstract][Full Text] [Related]
6. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
7. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonography features of medullary thyroid cancer as predictors of its biological behavior.
Kim C; Baek JH; Ha E; Lee JH; Choi YJ; Song DE; Kim JK; Chung KW; Kim WB; Shong YK
Acta Radiol; 2017 Apr; 58(4):414-422. PubMed ID: 27461223
[TBL] [Abstract][Full Text] [Related]
9. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound features of medullary thyroid cancer as predictors of biological behavior.
Zhao J; Zheng X; Gao M; Zhang S; Yun X; Chi J; Xu G
Cancer Imaging; 2021 Apr; 21(1):33. PubMed ID: 33836831
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
[No Abstract] [Full Text] [Related]
12. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of [
Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
15. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
16. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.
Momin S; Chute D; Burkey B; Scharpf J
Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
[TBL] [Abstract][Full Text] [Related]
17. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
[No Abstract] [Full Text] [Related]
19. Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
Park H; Park SY; Park J; Choe JH; Chung MK; Woo SY; Choi JY; Kim SW; Chung JH; Kim TH
Front Endocrinol (Lausanne); 2021; 12():749973. PubMed ID: 34675884
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided laser ablation for local control of neck recurrences of medullary thyroid cancer. A feasibility study.
Persichetti A; Bizzarri G; Guglielmi R; Barnabei A; Bianchini A; Coccaro C; Appetecchia M; Papini E
Int J Hyperthermia; 2018; 35(1):480-492. PubMed ID: 30204004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]